Targeting oncogenic and epigenetic survival pathways in lymphoma.
about
Role of alpha-synuclein in autophagy modulation of primary human T lymphocytesNew therapies in non-Hodgkin lymphoma.Activity of BKM120 and BEZ235 against Lymphoma Cells.Precision medicine in diffuse large B-cell lymphoma: hitting the target.Efficacy, safety, pharmacokinetics and pharmacodynamics of SAR245409 (voxtalisib, XL765), an orally administered phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor: a phase 1 expansion cohort in patients with relapsed or refractory ly
P2860
Targeting oncogenic and epigenetic survival pathways in lymphoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting oncogenic and epigenetic survival pathways in lymphoma.
@en
type
label
Targeting oncogenic and epigenetic survival pathways in lymphoma.
@en
prefLabel
Targeting oncogenic and epigenetic survival pathways in lymphoma.
@en
P2860
P1433
P1476
Targeting oncogenic and epigenetic survival pathways in lymphoma.
@en
P2093
Anas Younes
Lori A Leslie
P2860
P304
P356
10.3109/10428194.2013.780288
P577
2013-04-22T00:00:00Z